Alpha Tau Medical Stock EBITDA
| DRTS Stock | USD 2.80 0.06 2.10% |
Alpha Tau Medical fundamentals help investors to digest information that contributes to Alpha Tau's financial success or failures. It also enables traders to predict the movement of Alpha Stock. The fundamental analysis module provides a way to measure Alpha Tau's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alpha Tau stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -28 M | -29.4 M |
Alpha | EBITDA |
Alpha Tau Medical Company EBITDA Analysis
Alpha Tau's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Alpha Tau EBITDA | (28.03 M) |
Most of Alpha Tau's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Alpha Tau Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Alpha EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Alpha Tau is extremely important. It helps to project a fair market value of Alpha Stock properly, considering its historical fundamentals such as EBITDA. Since Alpha Tau's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Alpha Tau's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Alpha Tau's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Alpha Ebitda
Ebitda |
|
According to the company disclosure, Alpha Tau Medical reported earnings before interest,tax, depreciation and amortization of (28.03 Million). This is 103.19% lower than that of the Biotechnology sector and 127.98% lower than that of the Health Care industry. The ebitda for all United States stocks is 100.72% higher than that of the company.
Alpha EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alpha Tau's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alpha Tau could also be used in its relative valuation, which is a method of valuing Alpha Tau by comparing valuation metrics of similar companies.Alpha Tau is currently under evaluation in ebitda category among its peers.
Alpha Tau ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Alpha Tau's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alpha Tau's managers, analysts, and investors.Environmental | Governance | Social |
Alpha Tau Institutional Holders
Institutional Holdings refers to the ownership stake in Alpha Tau that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Alpha Tau's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Alpha Tau's value.| Shares | Northern Trust Corp | 2024-09-30 | 22.9 K | Aptus Capital Advisors, Llc | 2024-06-30 | 21.9 K | Citadel Advisors Llc | 2024-09-30 | 16.3 K | Renaissance Technologies Corp | 2024-09-30 | 14.2 K | Tuttle Capital Management, Llc | 2024-09-30 | 12.2 K | Usadvisors Wealth Management, Llc | 2024-09-30 | 10.7 K | Opal Wealth Advisors, Llc | 2024-09-30 | 10 K | Steward Partners Investment Advisory, Llc | 2024-06-30 | 6 K | Tower View Investment Management & Research Llc | 2024-09-30 | 5.6 K | Easterly Investment Partners. | 2024-09-30 | 307.3 K | Hoylecohen, Llc | 2024-06-30 | 269.1 K |
Alpha Fundamentals
| Return On Equity | -0.33 | ||||
| Return On Asset | -0.22 | ||||
| Current Valuation | 143.63 M | ||||
| Shares Outstanding | 70.1 M | ||||
| Shares Owned By Insiders | 25.56 % | ||||
| Shares Owned By Institutions | 1.94 % | ||||
| Number Of Shares Shorted | 65.21 K | ||||
| Price To Book | 2.83 X | ||||
| EBITDA | (28.03 M) | ||||
| Net Income | (29.16 M) | ||||
| Cash And Equivalents | 112.04 M | ||||
| Cash Per Share | 1.63 X | ||||
| Total Debt | 13.28 M | ||||
| Current Ratio | 41.98 X | ||||
| Book Value Per Share | 1.21 X | ||||
| Cash Flow From Operations | (17.96 M) | ||||
| Short Ratio | 3.01 X | ||||
| Earnings Per Share | (0.43) X | ||||
| Target Price | 8.75 | ||||
| Number Of Employees | 121 | ||||
| Beta | 0.77 | ||||
| Market Capitalization | 196.29 M | ||||
| Total Asset | 107.39 M | ||||
| Retained Earnings | (115.76 M) | ||||
| Working Capital | 78.65 M | ||||
| Net Asset | 107.39 M |
About Alpha Tau Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alpha Tau Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alpha Tau using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alpha Tau Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Alpha Stock Analysis
When running Alpha Tau's price analysis, check to measure Alpha Tau's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alpha Tau is operating at the current time. Most of Alpha Tau's value examination focuses on studying past and present price action to predict the probability of Alpha Tau's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alpha Tau's price. Additionally, you may evaluate how the addition of Alpha Tau to your portfolios can decrease your overall portfolio volatility.